✦ LIBER ✦

Comparison of the Pharmacokinetics of Albendazole and its Major Metabolites after Oral Administration of Albendazole as a Suspension and as a Paste Formulation to Sheep

✍ Scribed by Marriner, S. E. ;Bogan, J. A. ;Vandaele, W.

Book ID: 115161885
Publisher: Wiley (Blackwell Publishing)
Year: 2010
Weight: 375 KB
Volume: 28
Category: Article
ISSN: 0931-2021
DOI: 10.1111/j.1439-0450.1981.tb01736.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic evaluation of tramadol a

Pharmacokinetic evaluation of tramadol and its major metabolites after single oral sustained tablet administration in the dog: a pilot study

✍ Mario Giorgi; Giuseppe Saccomanni; Beata Łebkowska-Wieruszewska; Cezary Kowalski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Apparent absorption kinetics of microniz

Apparent absorption kinetics of micronized griseofulvin after its oral administration on single- and multiple-dose regimens to rats as a corn oil-in-water emulsion and aqueous suspension

✍ Theodore R. Bates; Philip J. Carrigan 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 684 KB

Glucagon-like peptide-1-(9-36) amide is

Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor

✍ Lotte Bjerre Knudsen; Lone Pridal 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 545 KB

Effects of E. Coli lipopolysaccharide on

Effects of E. Coli lipopolysaccharide on the pharmacokinetics of ipriflavone and its metabolites, M1 and M5, after intravenous and oral administration of ipriflavone to rats: Decreased metabolism of ipriflavone due to decreased expression of hepatic CYP1A2 and 2C11

✍ Hye J. Chung; Hee E. Kang; Eun J. Bae; Inchul Lee; Sang G. Kim; Myung G. Lee 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 1 views

It was reported that ipriflavone was primarily metabolized via hepatic CYP1A1/2 and 2C11 in rats. In the present study, the expression of CYP1A2 and 2C11 decreased in the liver, but increased in the intestine in rats pretreated with E. coli lipopolysaccharide (ECLPS; an animal model of inflammation)